Tags : Resumes

AstraZeneca Resumes COVID-19 Vaccine Trials in the UK

Shots: AstraZeneca has resumed the clinical trial of AZD1222 in the UK, following the MHRA’s confirmation that it is safe to resume the trial On Sept 06, 2020, the standard review process triggered a voluntary pause to all global trials, allowing review of safety data by independent committees, and international regulators. The UK committee has […]Read More

Novo Nordisk Resumes P-III Study of Concizumab for Patients with

Shots: The company resumes the P-III program (explorer6, 7, and 8) of concizumab. The clinical trials are evaluating concizumab (SC) prophylaxis treatment in hemophilia A and B patients regardless of their inhibitor status The trials will be resumed as soon as local procedures allow. This follows pausing of the trials in Mar’20 due to the […]Read More